Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000259290 refers to a **novel transcript that is sense-oriented and located within an intron of the PKNOX2 gene**, based on RNA gene annotation.[1] There is no evidence it codes for a protein or serves as a classic therapeutic target such as a receptor, enzyme, transporter, or transcription factor. No canonical function, biological role, or involvement in disease has been established, nor is there evidence for drug interactions, mechanisms of action, biomarker utility, or safety concerns. Much of the information, including aliases and classification, remains undefined or unknown, which is common for non-coding novel transcripts identified by RNA sequencing and genomic annotation projects. This record likely represents a predicted or poorly characterized RNA gene, rather than a classical therapeutic target.[1]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to PKNOX2 (ENSG00000259290).